165 related articles for article (PubMed ID: 7668898)
1. Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis.
Marhoffer W; Stracke H; Masoud I; Scheja M; Graef V; Bolten W; Federlin K
Ann Rheum Dis; 1995 Jul; 54(7):556-9. PubMed ID: 7668898
[TBL] [Abstract][Full Text] [Related]
2. Biochemical bone turnover markers in patients with ankylosing spondylitis.
Yilmaz N; Ozaslan J
Clin Rheumatol; 2000; 19(2):92-8. PubMed ID: 10791618
[TBL] [Abstract][Full Text] [Related]
3. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis.
Toussirot E; Ricard-Blum S; Dumoulin G; Cedoz JP; Wendling D
Rheumatology (Oxford); 1999 Jan; 38(1):21-7. PubMed ID: 10334678
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
Mitra D; Elvins DM; Collins AJ
J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
[TBL] [Abstract][Full Text] [Related]
5. Markers of bone turnover in hyperthyroidism and the effects of treatment.
Garnero P; Vassy V; Bertholin A; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Apr; 78(4):955-9. PubMed ID: 8157727
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
[TBL] [Abstract][Full Text] [Related]
7. Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis.
Park MC; Chung SJ; Park YB; Lee SK
Yonsei Med J; 2008 Apr; 49(2):288-94. PubMed ID: 18452267
[TBL] [Abstract][Full Text] [Related]
8. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
Uebelhart D; Schlemmer A; Johansen JS; Gineyts E; Christiansen C; Delmas PD
J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
[TBL] [Abstract][Full Text] [Related]
9. Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis.
Lange U; Teichmann J; Stracke H
Eur J Med Res; 2000 Dec; 5(12):507-11. PubMed ID: 11147993
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of pyridinium cross-links and serum osteocalcin levels in patients with primary high-grade osteosarcoma.
Ferrari S; Zolezzi C; Pratelli L; Fasano MC; Bacci G
Calcif Tissue Int; 2003 Jul; 73(1):1-4. PubMed ID: 14506946
[TBL] [Abstract][Full Text] [Related]
11. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
[TBL] [Abstract][Full Text] [Related]
12. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
13. [Collagen breakdown in ankylosing spondylitis-relationship to disease related parameters].
Bölzner C; Müller A; Bräunig E; Hein G
Z Rheumatol; 2003 Oct; 62(5):459-67. PubMed ID: 14579033
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity.
MacDonald AG; Birkinshaw G; Durham B; Bucknall RC; Fraser WD
Br J Rheumatol; 1997 Jan; 36(1):50-3. PubMed ID: 9117174
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
16. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis.
Franck H; Keck E
Ann Rheum Dis; 1993 May; 52(5):343-6. PubMed ID: 8323382
[TBL] [Abstract][Full Text] [Related]
17. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
18. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
19. Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis.
Almodóvar R; Ríos V; Ocaña S; Gobbo M; Casas ML; Zarco-Montejo P; Juanola X
Clin Rheumatol; 2014 Feb; 33(2):237-41. PubMed ID: 23917391
[TBL] [Abstract][Full Text] [Related]
20. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis.
Lange U; Jung O; Teichmann J; Neeck G
Osteoporos Int; 2001 Dec; 12(12):1031-5. PubMed ID: 11846329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
